{"id":"doxorubicin-hydrochloride-hcl","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Myelosuppression"},{"rate":"2-5%","effect":"Cardiotoxicity"},{"rate":"10-30%","effect":"Neutropenia"}]},"_chembl":{"chemblId":"CHEMBL584759","moleculeType":"Small molecule","molecularWeight":"579.99"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Doxorubicin hydrochloride works by intercalating DNA strands and inhibiting the enzyme topoisomerase II, which is necessary for DNA replication and transcription.","oneSentence":"Topoisomerase II inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:11:14.880Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hodgkin's lymphoma"},{"name":"Breast cancer"},{"name":"Lung cancer"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Doxorubicin Hydrochloride [HCl]","genericName":"Doxorubicin Hydrochloride [HCl]","companyName":"Genmab","companyId":"genmab","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Topoisomerase II inhibitor Used for Hodgkin's lymphoma, Breast cancer, Lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}